StockData

Mosaic ImmunoEngineering Inc. (CPMV) stock

CPMVOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.33+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.41MP/E –Yield –

Mosaic ImmunoEngineering cash

Cash and short-term investments held at the end of each period.

Mosaic ImmunoEngineering's cash was $26 at Jun 30, 2026. For fiscal 2025 it was $3.62K, down 96.9% from the year before. Over ten years it grew -52.7% a year on average. The highest annual figure on record is $10.66M in fiscal 2011.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.62K-96.9%
FY2024Dec 31, 2024$115.02K-26.4%
FY2023Dec 31, 2023$156.18K-29.2%
FY2022Dec 31, 2022$220.65K+44029.0%
FY2020May 31, 2020$500-100.0%
FY2019May 31, 2019$1.54M-33.7%
FY2018May 31, 2018$2.32M-27.6%
FY2017May 31, 2017$3.20M+2.9%
FY2016May 31, 2016$3.12M-39.3%
FY2015May 31, 2015$5.13M-20.0%
FY2014May 31, 2014$6.42M-17.4%
FY2013May 31, 2013$7.77M+2.1%
FY2012May 31, 2012$7.61M-28.7%
FY2011May 31, 2011$10.66M+3.1%
FY2010May 31, 2010$10.34M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$26-100.0%
Q1 FY2026CQ1 2026Mar 31, 2026$72-99.9%
Q4 FY2025CQ4 2025Dec 31, 2025$3.62K-96.9%
Q3 FY2025CQ3 2025Sep 30, 2025$31.76K+453.7%
Q2 FY2025CQ2 2025Jun 30, 2025$53.58K+1335.0%
Q1 FY2025CQ1 2025Mar 31, 2025$85.93K+32.1%
Q4 FY2024CQ4 2024Dec 31, 2024$115.02K-26.4%
Q3 FY2024CQ3 2024Sep 30, 2024$5.74K-97.7%
Q2 FY2024CQ2 2024Jun 30, 2024$3.73K-99.0%
Q1 FY2024CQ1 2024Mar 31, 2024$65.04K-48.3%
Q4 FY2023CQ4 2023Dec 31, 2023$156.18K-29.2%
Q3 FY2023CQ3 2023Sep 30, 2023$252.90K-34.2%
Q2 FY2023CQ2 2023Jun 30, 2023$362.97K+76.2%
Q1 FY2023CQ1 2023Mar 31, 2023$125.78K-66.7%
Q4 FY2022CQ4 2022Dec 31, 2022$220.65K+44029.0%
Q3 FY2022CQ3 2022Sep 30, 2022$384.14K-48.7%
Q2 FY2022CQ2 2022Jun 30, 2022$205.99K-78.6%
Q1 FY2022CQ1 2022Mar 31, 2022$378.06K-69.5%
Q4 FY2020CQ2 2020May 31, 2020$500-100.0%
Q3 FY2020CQ1 2020Feb 29, 2020$748.83K-57.6%
Q2 FY2020CQ4 2019Nov 30, 2019$963.00K-48.6%
Q1 FY2020CQ3 2019Aug 31, 2019$1.24M-39.2%
Q4 FY2019CQ2 2019May 31, 2019$1.54M-33.7%
Q3 FY2019CQ1 2019Feb 28, 2019$1.77M-29.7%
Q2 FY2019CQ4 2018Nov 30, 2018$1.87M-30.7%
Q1 FY2019CQ3 2018Aug 31, 2018$2.04M-31.0%
Q4 FY2018CQ2 2018May 31, 2018$2.32M-27.6%
Q3 FY2018CQ1 2018Feb 28, 2018$2.51M-24.3%
Q2 FY2018CQ4 2017Nov 30, 2017$2.70M-18.2%
Q1 FY2018CQ3 2017Aug 31, 2017$2.95M+9.7%
Q4 FY2017CQ2 2017May 31, 2017$3.20M+2.9%
Q3 FY2017CQ1 2017Feb 28, 2017$3.32M-10.9%
Q2 FY2017CQ4 2016Nov 30, 2016$3.30M-19.1%
Q1 FY2017CQ3 2016Aug 31, 2016$2.69M-41.4%
Q4 FY2016CQ2 2016May 31, 2016$3.12M-39.3%
Q3 FY2016CQ1 2016Feb 29, 2016$3.72M-31.9%
Q2 FY2016CQ4 2015Nov 30, 2015$4.08M–
Q1 FY2016CQ3 2015Aug 31, 2015$4.60M–
Q4 FY2015CQ2 2015May 31, 2015$5.13M–
Q3 FY2015CQ1 2015Feb 28, 2015$5.47M–

More Mosaic ImmunoEngineering figures

See a number that looks wrong?